Tracking in-situ checkpoint inhibitor bound target T cells in checkpoint colitis : Additional Data

Published: 17 April 2024| Version 1 | DOI: 10.17632/7z8yx644hb.1
Contributors:
Tarun Gupta, Agne Antanaviciute, Chloe Hyun-Jung Lee, Rosana Babu, Anna Aulicino, Zoe Christoforidou, Paulina Siejka-Zielinska, Caitlin O'Brien-Ball, Hannah Chen, David Fawkner-Corbett, Ana Gerós, Esther Bridges, Colleen McGregor, Nicole Cianci, Eve Fryer, Nasullah Khalid Alham, Marta Jagielowicz, Mafalda Da Cunha Santos, Martin Fellermeyer, Simon Davis, kaushal parikh, Vincent Ting Fung Cheung, Lulia Al-Hillawi, Sarah Sasson, Stephanie Slevin, Oliver Brain, Ricardo Fernandes, Hashem Koohy, Alison Simmons

Description

Additional Tables and Data for "Tracking in-situ checkpoint inhibitor bound target T cells in checkpoint colitis" by Gupta et al. Patients with Checkpoint inhibitor-induced colitis (CPI_colitis), Checkpoint inhibitor treatment without colitis (CPI_control), Ulcerative colitis (UC_I/UC) and Healthy Controls (HC) investigated with single-cell RNA sequencing and spatial transcriptomics

Files

Institutions

  • Weatherall Institute of Molecular Medicine
  • University of Oxford Oxford Translational Gastroenterology Unit
  • University of Oxford

Categories

Inflammatory Bowel Disease, Ulcerative Colitis, Immunotherapy, Immunohistochemistry, Immune Checkpoint Blockade, Single-Cell RNA Sequencing, Immune Checkpoint Inhibitor, Immunofluorescence, Spatial Transcriptomics

Licence